一家英国药企公司在中国上演的这场黑金游戏中,每个人既是行贿者也是受惠者。这是一个制度性的困局,不能简单地以道德的眼光评判是非。2013年7月中旬,因贿赂门事件,全球知名英国药企葛兰素史克公司更多地被国人所知晓。包括4名高管在内的超过20名药企和4家旅行社的工作人员被警方立案侦查。据悉,作为在华规模最大的跨国制药企业之一的葛兰素史克公司曾在美国、意大利、新西兰等国涉嫌违规行为被处以高额罚款。 In this black gold game played by a British pharmaceutical company in China, everyone is a bribe-maker and a beneficiary. This is a systematic dilemma that can not be simply judged morally. In mid-July 2013, the global well-known British pharmaceutical company GlaxoSmithKline was more known to the public because of bribery. More than 20 pharmaceutical companies and 4 travel agencies, including 4 executives, were placed on file for investigation. It is reported that as one of the largest multinational pharmaceutical companies in China GlaxoSmithKline company in the United States, Italy, New Zealand and other countries suspected of irregularities were fined fines.